Your browser doesn't support javascript.
loading
Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions.
Mayo-de-Las-Casas, C; Jordana-Ariza, N; Garzón-Ibañez, M; Balada-Bel, A; Bertrán-Alamillo, J; Viteri-Ramírez, S; Reguart, N; Muñoz-Quintana, M A; Lianes-Barragan, P; Camps, C; Jantús, E; Remon-Massip, J; Calabuig, S; Aguiar, D; Gil, M L; Viñolas, N; Santos-Rodríguez, A K; Majem, M; García-Peláez, B; Villatoro, S; Pérez-Rosado, A; Monasterio, J C; Ovalle, E; Catalán, M J; Campos, R; Morales-Espinosa, D; Martínez-Bueno, A; González-Cao, M; González, X; Moya-Horno, I; Sosa, A E; Karachaliou, N; Rosell, R; Molina-Vila, M A.
Afiliación
  • Mayo-de-Las-Casas C; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona.
  • Jordana-Ariza N; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona.
  • Garzón-Ibañez M; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona.
  • Balada-Bel A; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona.
  • Bertrán-Alamillo J; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona.
  • Viteri-Ramírez S; Dr Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona.
  • Reguart N; Department of Medical Oncology, Hospital Clínic, Barcelona.
  • Muñoz-Quintana MA; Department of Medical Oncology, Valencia Institute of Oncology, Valencia.
  • Lianes-Barragan P; Department of Medical Oncology, Mataró Hospital, Mataró.
  • Camps C; Molecular Oncology Laboratory, Fundación Investigación, Valencia General University Hospital, Valencia.
  • Jantús E; CIBERONC, Valencia.
  • Remon-Massip J; Medical Oncology Department, Valencia General University Hospital, Valencia.
  • Calabuig S; Department of Medicine, Universitat de València.
  • Aguiar D; Molecular Oncology Laboratory, Fundación Investigación, Valencia General University Hospital, Valencia.
  • Gil ML; CIBERONC, Valencia.
  • Viñolas N; Department of Biotechnology, Universitat Politècnica de València.
  • Santos-Rodríguez AK; Department of Medical Oncology, Mataró Hospital, Mataró.
  • Majem M; Molecular Oncology Laboratory, Fundación Investigación, Valencia General University Hospital, Valencia.
  • García-Peláez B; CIBERONC, Valencia.
  • Villatoro S; Department of Biotechnology, Universitat Politècnica de València.
  • Pérez-Rosado A; Department of Medical Oncology, Hospital Dr Negrín of Gran Canaria, Las Palmas.
  • Monasterio JC; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona.
  • Ovalle E; Department of Medical Oncology, Hospital Clínic, Barcelona.
  • Catalán MJ; Department of Medical Oncology, Virgen de la Salud Hospital, Toledo.
  • Campos R; Medical Oncology Service, Hospital de Sant Pau, Barcelona.
  • Morales-Espinosa D; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona.
  • Martínez-Bueno A; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona.
  • González-Cao M; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona.
  • González X; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona.
  • Moya-Horno I; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona.
  • Sosa AE; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona.
  • Karachaliou N; Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona.
  • Rosell R; Dr Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona.
  • Molina-Vila MA; Dr Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona.
Ann Oncol ; 28(9): 2248-2255, 2017 Sep 01.
Article en En | MEDLINE | ID: mdl-28911086

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Receptores ErbB / Neoplasias Pulmonares / Mutación Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Receptores ErbB / Neoplasias Pulmonares / Mutación Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article